Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Tofacitinib is more effective than methotrexate for treating moderate-to-severe alopecia areata.

Combining 5% spironolactone and 5% minoxidil is safe and more effective for treating hair loss.

Dutasteride is more effective than finasteride for hair loss, but more research is needed on safety and dosing.

The Turkish version of the Alopecia Areata Quality of Life Index is reliable and valid.

Medium-dose prednisolone pulse therapy is effective and safe for multifocal alopecia areata but not for more severe forms.

Finasteride and dutasteride both improve hair growth effectively, but dutasteride has stronger anti-androgen effects and finasteride may cause more sexual side effects.

Oral lichen planus is not linked to sex hormone levels.

Lower vitamin D levels are linked to more severe alopecia areata.

Vitamin D3 is a safe and effective alternative to steroids for treating alopecia areata, with fewer side effects.

A 300 mg monthly pulse of prednisolone effectively and safely treats widespread alopecia areata.

Ritlecitinib improved hair regrowth and emotional well-being in some alopecia areata patients.

Baricitinib 4 mg is effective and safe for treating severe alopecia areata.

Low-dose oral minoxidil can cause serious side effects like heart issues, so use the lowest effective dose.

Dithranol reduces inflammation in alopecia areata by lowering certain immune responses.

Oral baricitinib is effective and safe for treating alopecia areata.

Start low-dose minoxidil gradually, especially for women, to reduce side effects.

Alopecia areata and androgenetic alopecia affect quality of life similarly.

CP-690,550 significantly reduced itching in patients with moderate-to-severe plaque psoriasis.

Alopecia negatively affects quality of life and mental health.

The study developed methods to measure biomarkers in mice and found differences in hormone levels linked to gut microbiota diversity and stress response.

Brodalumab is more effective than ustekinumab for treating psoriasis.

Apremilast was not effective in treating moderate-to-severe alopecia areata.

Dithranol is more effective than Tacrolimus for hair regrowth in alopecia areata.

The new dutasteride gel improves hair growth for treating baldness.

Over 45% of patients with alopecia areata benefit from ritlecitinib, mostly within a year.

Dermatologists should monitor potassium levels in women taking spironolactone for acne, hair loss, and hirsutism.

Patients and clinicians generally agree on eyebrow and eyelash hair loss improvements in severe alopecia areata.